ID

26895

Descripción

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02; ODM derived from: https://clinicaltrials.gov/show/NCT00963417

Link

https://clinicaltrials.gov/show/NCT00963417

Palabras clave

Versiones (1)
  1. 28/10/17 28/10/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

28 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00963417

Inglés

Eligibility Breast Cancer NCT00963417

1 formularios  
Criteria
Descripción

Criteria

patient must be eligible and enrolled in the text-2 trial prior to enrolling in text-bone
Descripción

Study Subject Participation Status | Clinical Trial Specified

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C0205369
serial bone marrow density (bmd) measurements must be taken within the same institution
Descripción

Bone Mineral Density Test Series

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0177804
UMLS CUI [1,2]
C0205549
hormone receptor positive
Descripción

Hormone Receptor Positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C1446409
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
see disease characteristics
Descripción

ID.5

Tipo de datos

boolean

premenopausal
Descripción

Premenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232969
no bone fracture in the past 6 months that, in the investigator's judgement, could be related to bone fragility
Descripción

Exclusion | Bone fracture Relationship Bone fragility

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0016658
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C1390474
no clinical or biochemical malabsorption syndrome, known vitamin d deficiency, active hyper- or hypoparathyroidism, or paget's disease
Descripción

Exclusion Criteria | Malabsorption Syndrome Biochemical | Vitamin D Deficiency | Hyperparathyroidism | Hypoparathyroidism | Paget's disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0024523
UMLS CUI [2,2]
C0205474
UMLS CUI [3]
C0042870
UMLS CUI [4]
C0020502
UMLS CUI [5]
C0020626
UMLS CUI [6]
C0029401
no uncontrolled thyroid disease, cushing disease, or other pituitary diseases
Descripción

Exclusion Criteria | Thyroid Disease Uncontrolled | Cushing's disease | Pituitary Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0040128
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0221406
UMLS CUI [4]
C0032002
no other bone disease (including osteomalacia or osteogenesis imperfecta)
Descripción

Exclusion Criteria | Bone Diseases | Osteomalacia | Osteogenesis Imperfecta

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0005940
UMLS CUI [3]
C0029442
UMLS CUI [4]
C0029434
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Descripción

ID.12

Tipo de datos

boolean

at least 6 months since prior and no concurrent bisphosphonate therapy (or other bone therapies such as pth or strontium)
Descripción

Exclusion Criteria | Diphosphonates | Bone disorder therapy | Parathyroid hormone therapy | Strontium

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0012544
UMLS CUI [3]
C0872270
UMLS CUI [4]
C3839506
UMLS CUI [5]
C0038467
at least 6 months since prior glucocorticoid (> 5 mg prednisone or equivalent) for > 1 month
Descripción

Glucocorticoids | Prednisone Dose | Equivalent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2,1]
C0032952
UMLS CUI [2,2]
C0178602
UMLS CUI [3]
C0205163
at least 12 months since prior anticonvulsants
Descripción

Anticonvulsants

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003286
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00963417

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Study Subject Participation Status | Clinical Trial Specified
Item
patient must be eligible and enrolled in the text-2 trial prior to enrolling in text-bone
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
Bone Mineral Density Test Series
Item
serial bone marrow density (bmd) measurements must be taken within the same institution
boolean
C0177804 (UMLS CUI [1,1])
C0205549 (UMLS CUI [1,2])
Hormone Receptor Positive
Item
hormone receptor positive
boolean
C0019929 (UMLS CUI [1,1])
C1446409 (UMLS CUI [1,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ID.5
Item
see disease characteristics
boolean
Premenopausal state
Item
premenopausal
boolean
C0232969 (UMLS CUI [1])
Exclusion | Bone fracture Relationship Bone fragility
Item
no bone fracture in the past 6 months that, in the investigator's judgement, could be related to bone fragility
boolean
C2828389 (UMLS CUI [1])
C0016658 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C1390474 (UMLS CUI [2,3])
Exclusion Criteria | Malabsorption Syndrome Biochemical | Vitamin D Deficiency | Hyperparathyroidism | Hypoparathyroidism | Paget's disease
Item
no clinical or biochemical malabsorption syndrome, known vitamin d deficiency, active hyper- or hypoparathyroidism, or paget's disease
boolean
C0680251 (UMLS CUI [1])
C0024523 (UMLS CUI [2,1])
C0205474 (UMLS CUI [2,2])
C0042870 (UMLS CUI [3])
C0020502 (UMLS CUI [4])
C0020626 (UMLS CUI [5])
C0029401 (UMLS CUI [6])
Exclusion Criteria | Thyroid Disease Uncontrolled | Cushing's disease | Pituitary Diseases
Item
no uncontrolled thyroid disease, cushing disease, or other pituitary diseases
boolean
C0680251 (UMLS CUI [1])
C0040128 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0221406 (UMLS CUI [3])
C0032002 (UMLS CUI [4])
Exclusion Criteria | Bone Diseases | Osteomalacia | Osteogenesis Imperfecta
Item
no other bone disease (including osteomalacia or osteogenesis imperfecta)
boolean
C0680251 (UMLS CUI [1])
C0005940 (UMLS CUI [2])
C0029442 (UMLS CUI [3])
C0029434 (UMLS CUI [4])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.12
Item
see disease characteristics
boolean
Exclusion Criteria | Diphosphonates | Bone disorder therapy | Parathyroid hormone therapy | Strontium
Item
at least 6 months since prior and no concurrent bisphosphonate therapy (or other bone therapies such as pth or strontium)
boolean
C0680251 (UMLS CUI [1])
C0012544 (UMLS CUI [2])
C0872270 (UMLS CUI [3])
C3839506 (UMLS CUI [4])
C0038467 (UMLS CUI [5])
Glucocorticoids | Prednisone Dose | Equivalent
Item
at least 6 months since prior glucocorticoid (> 5 mg prednisone or equivalent) for > 1 month
boolean
C0017710 (UMLS CUI [1])
C0032952 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205163 (UMLS CUI [3])
Anticonvulsants
Item
at least 12 months since prior anticonvulsants
boolean
C0003286 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial